ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Legislation that would grant independent pharmacists collective bargaining rights
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Medicare/Medicaid MMM
Proposed changes to the Medicare Part D prescription drug benefit; adjustment to Medicaid prescription drug reimbursement rates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Pharmacy PHA
Legislation relating to to pharmacy issues and the professional role of pharmacists; legislation relating to medication therapy management programs and funding for said programs; legislation relating to importation of prescription drugs; legislation granting the FDA authority to approve follow-on biologic products; legislation relating to settlement agreements between brand-name and generic manufacturers; legislation promoting the use of generic drugs generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Health Issues HCR
Health care reform legislation with respect to pharmacy issues and the professional role of pharmacists; increased federal funding for comparative effectiveness research; establishment of a public-private entity to coordinate comparative effectiveness research; legislation relating to health information technology and electronic prescribing; appropriations for the U.S. Food and Drug Administration and the Agency for Healthcare Research and Quality
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| ADRIANNE DROLLETTE | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.